U.S. stocks were higher, with the Dow Jones index gaining more than 400 points on Monday.

Shares of BridgeBio Pharma, Inc. BBIO rose sharply during Monday’s session after the company announced that the FDA approved Attruby to treat adults with ATTR-CM.

On Friday, the FDA approved BridgeBio Pharma’s Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for adults with ATTR-CM to reduce cardiovascular death and cardiovascular-related hospitalization. Also, HC Wainwright maintained a Buy rating on the stock and raised its price target from $43 to $49.

BridgeBio Pharma shares jumped 22.3% to $28.64 on Monday.

Here are some other big stocks recording gains in today’s session.

• Rigetti Computing, Inc. RGTI shares jumped 69% to $2.9289 after the company completed a $100 million at-the-market equity offering, with plans to use the proceeds for working capital, capital expenditures, and advancements in superconducting quantum computing technology.
• Scholar Rock Holding Corporation SRRK gained 27.2% to $38.03. Scholar Rock Holding recently reported worse-than-expected third-quarter EPS results.
• D-Wave Quantum Inc. QBTS surged 26.3% to $3.6800 after AWS announced Quantum Embark program.
• Mercurity Fintech Holding Inc. MFH gained 23.3% to $6.15.
• Quantum Computing Inc. QUBT rose 19% to $7.26 after AWS announced Quantum Embark program.
• Eastman Kodak Company KODK surged 17.4% to $6.18.
• Super Micro Computer, Inc. SMCI rose 16.6% to $38.36.
• Eve Holding, Inc. EVEX gained 16.6% to $3.9062.
• Bath & Body Works, Inc. BBWI shares climbed 15.5% to $35.49 after the company reported better-than-expected third-quarter EPS and sales and raised its 2024 guidance.
• Archer Aviation Inc. ACHR surged 14.6% to $6.92.
• Hims & Hers Health, Inc. HIMS rose 13.5% to $28.77.
• Iovance Biotherapeutics, Inc. IOVA gained 11.3% to $9.52.
• Clarivate Plc CLVT rose 8.7% to $5.70.
• Flagstar Financial, Inc. FLG gained 7.1% to $12.52.
• Five Below, Inc. FIVE climbed 6.8% to $92.82. Five Below will release its financial results for the third quarter of fiscal 2024 after the closing bell on Wednesday, Dec. 4.
• Moderna, Inc. MRNA climbed 6.3% to $43.74.
• Jones Lang LaSalle Incorporated JLL gained 6.1% to $279.28. Wolfe Research analyst Andrew Rosivach upgraded Jones Lang LaSalle from Peer Perform to Outperform and announced a $353 price target.
• Elastic N.V. ESTC rose 6% to $114.49 after Wedbush upgraded the stock from Neutral to Outperform and announced a $135 price target.

Now Read This: